EFFECTIVENESS AND SAFETY OF THE SWITCH FROM REMICADE<sup>®</sup> TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Maria Chaparro Sanchez 1
A Garre 1
Maria Fernanda Guerra Veloz 2
J M Vázquez 3
M L De Castro 4
Eduardo Leo Carnerero 5
E Rodríguez
A Y Carbajo
Sabino Riestra Menéndez
I Jiménez
Xavier Calvet Calvo
Luis Bujanda
Montserrat Rivero
Fernando Gomollón
Jose Manuel Benitez
Fernando Bermejo
Noelia Alcaide
Ana Gutierrez Casbas;
1 Hospital Universitario de La Princesa, IIS-IP and CIBERehd,Madrid,Spain
2 Hospital Universitario Virgen Macarena,Sevilla,Spain
3 Hospital Juan Ramón Jiménez,Huelva,Spain
4 Complejo Hospitalario Universitario de Vigo,Vigo,Spain
5 Hospital Universitario Virgen del Rocí
Conference
UEG Week 2018
Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]